PT3476391T - Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq - Google Patents
Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliqInfo
- Publication number
- PT3476391T PT3476391T PT178155057T PT17815505T PT3476391T PT 3476391 T PT3476391 T PT 3476391T PT 178155057 T PT178155057 T PT 178155057T PT 17815505 T PT17815505 T PT 17815505T PT 3476391 T PT3476391 T PT 3476391T
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016124992 | 2016-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3476391T true PT3476391T (pt) | 2021-11-09 |
Family
ID=60783349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT178155057T PT3476391T (pt) | 2016-06-23 | 2017-06-23 | Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq |
Country Status (7)
Country | Link |
---|---|
US (1) | US20190314311A1 (pt) |
EP (1) | EP3476391B1 (pt) |
JP (1) | JP6933380B2 (pt) |
CN (1) | CN109310659B (pt) |
ES (1) | ES2896224T3 (pt) |
PT (1) | PT3476391T (pt) |
WO (1) | WO2017222040A1 (pt) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10016527A1 (de) * | 2000-04-03 | 2001-10-18 | Max Planck Gesellschaft | Verfahren zur Diagnose von Krebserkrankungen und/oder neurodegenerativen Krankheitszuständen sowie Produkte dafür |
US8048923B2 (en) * | 2003-01-17 | 2011-11-01 | Odessa Pharma | Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides |
US20040235733A1 (en) * | 2003-02-27 | 2004-11-25 | Steffan Joan S. | Methods and reagents for reducing polyglutamine toxicity |
WO2013061161A2 (en) * | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
EP3063168B1 (en) * | 2013-10-30 | 2019-03-06 | University of Western Australia | Neuroprotective peptides |
-
2017
- 2017-06-23 ES ES17815505T patent/ES2896224T3/es active Active
- 2017-06-23 WO PCT/JP2017/023162 patent/WO2017222040A1/ja unknown
- 2017-06-23 JP JP2018524177A patent/JP6933380B2/ja active Active
- 2017-06-23 CN CN201780038090.5A patent/CN109310659B/zh active Active
- 2017-06-23 EP EP17815505.7A patent/EP3476391B1/en active Active
- 2017-06-23 PT PT178155057T patent/PT3476391T/pt unknown
- 2017-06-23 US US16/312,208 patent/US20190314311A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2017222040A1 (ja) | 2017-12-28 |
US20190314311A1 (en) | 2019-10-17 |
JPWO2017222040A1 (ja) | 2019-04-18 |
CN109310659A (zh) | 2019-02-05 |
ES2896224T3 (es) | 2022-02-24 |
EP3476391A1 (en) | 2019-05-01 |
EP3476391A4 (en) | 2020-03-04 |
EP3476391B1 (en) | 2021-08-11 |
CN109310659B (zh) | 2021-04-16 |
JP6933380B2 (ja) | 2021-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360B (en) | Pharmaceutical composition | |
IL265260B (en) | pharmaceutical preparations | |
IL262654A (en) | Pharmacy preparation | |
IL271986A (en) | pharmaceutical preparation | |
IL265349A (en) | Pharmaceutical composition | |
GB201712159D0 (en) | Pharmaceutical composition | |
PL3583943T3 (pl) | Kompozycja farmaceutyczna | |
IL272419A (en) | Pharmaceutical composition | |
GB201506526D0 (en) | Medicinal composition | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201521462D0 (en) | Pharmaceutical composition | |
GB201719447D0 (en) | Pharmaceutical composition | |
GB201615917D0 (en) | Pharmaceutical composition | |
GB201515310D0 (en) | Pharmaceutical composition | |
RS66245B1 (sr) | Farmaceutska kompozicija | |
PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
GB201615914D0 (en) | Pharmaceutical composition | |
GB201520862D0 (en) | Pharmaceutical composition | |
IL263999A (en) | Pharmaceutical compositions | |
GB201615910D0 (en) | Pharmaceutical composition | |
IL265436B (en) | Pharmacy preparation | |
ZA201705782B (en) | Pharmaceutical compositions | |
PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
GB201620519D0 (en) | Pharmaceutical composition | |
IL265428A (en) | Pharmaceutical composition |